This increases the expression of the CRC cell channel protein SLC7A11 (solute carrier family 7, membrane 11), and promotes glutamine uptake by the CRC cells, thereby enhancing the resistance of CRC to RT treatment. The gene discussed is SLC7A11; the disease is colorectal carcinoma.